Atrial Septal Defect Market Future Opportunities2017 - 2025
Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole is referred to as atrial septal defect. Huge and long-term atrial septal defects may lead to serious heart and lung damage. In some cases, extra blood volume can overfill the lungs and increases the blood pressure of the lungs, leading to pulmonary hypertension. Most of the congenital heart diseases are caused by certain genetic defects. The three most common types of atrial septal defects are ostium secundum atrial septal defect, ostium primum atrial septal defect and sinus venosus atrial septal. Various
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17066
symptoms associated with atrial septal defect are as follows:
Difficulty in breathing (dyspnea)
Frequent respiratory infections
Swelling of legs and feet
Global Atrial Septal Defect Market: Key Segments
Based on diagnosis, the atrial septal defect market can be segmented as follows:
Electrocardiogram (ECG): ECG records the electrical activity of an individual and identifies heart problems
Chest X-ray: With the help of X-ray, condition of the heart and lungs are detected
Cardiac catheterization: In this test, a catheter is inserted into the heart via vein and any congenital heart defects can be diagnosed including amount of oxygen in the blood
Transesophageal echocardiography (TEE): The test provides an ultrasound image to provide a clearer image of the atria
Pulse oximetry: This test helps to detect whether oxygenated blood is mixing with deoxygenated blood, thereby confirming any type of heart defect
The medications which are used to reduce the signs and symptoms of atrial septal defect include beta blockers (Lopressor, Inderal), anticoagulants (Coumadin) and anti-platelet agents (aspirin). In some instances, surgery is also done to repair an atrial septal defect such as open-heart surgery and cardiac catheterization.
Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=17066
Global Atrial Septal Defect Market: Regional Analysis
Based on geography, the atrial septal defect market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these regions, North America holds a leading position in the market followed by Europe. The prime factors which are driving the growth of atrial septal defect market in these regions are high prevalence of genetic heart disorders, and growing awareness of the population regarding atrial septal defects. Moreover, technological advancement in the treatment of congenital heart diseases is also accentuating the growth of the market. Asia Pacific is the most lucrative market for the growth of atrial septal defect market. The advantageous factors which would propel the growth of the market in Asia Pacific are presence of large population base and emerging economies such as China, Malaysia, India and Vietnam. Furthermore, favorable reimbursement policies and increasing disposable income of the Asian population would further boost the growth of atrial septal defect market in the coming years.
View Report: https://www.transparencymarketresearch.com/atrial-septal-defect-market.html
Global Atrial Septal Defect Market: Companies Mentioned in the Report
Various pharmaceutical companies are constantly trying to come up with novel therapeutic developments for the treatment of atrial septal defect. Some of the top major players operating in the atrial septal defect market are Asklepion Pharmaceuticals, LLC, Actelion Ltd., Novo Nordisk A/S, Abbott Laboratories, INO Therapeutics, LLC and others.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atrial Septal Defect Market Future Opportunities2017 - 2025 here
News-ID: 1019330 • Views: 247
More Releases from Transparency Market Research
Analysis of COVID-19 Crisis-driven Growth Opportunities in Laparoscopy Devices M …
Laparoscopy Devices Market: Introduction According to the report, the global laparoscopy devices market was valued at US$ 8.5 Bn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030. Laparoscopy, also called minimally invasive surgery, involves using keyhole surgical techniques or small incision. Instruments used for such surgeries are also unique and less invasive, and called laparoscopy devices. The key instrument used is a laparoscope,
Optometry Market Key Manufacturers, Development Trends and Competitive Analysis
Transparency Market Research (TMR) has published a new report titled, ‘Optometry Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global optometry market was valued at US$ 60.7 Bn in 2018 and is projected to expand at a CAGR of 4.3% from 2019 to 2027. Read Report Overview: https://www.transparencymarketresearch.com/optometry-market.html Overview • As optometry has evolved into the realm of therapeutics, the use of new technologies has
Medical Education Market is Booming Worldwide According to New Research Report
Medical Education Market: Introduction According to the report, the global medical education market was valued at ~US$ 32 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. Medical education is a highly practical field that calls for intense on-job training. The market for distance training is quite small; those attempting to gain certification through distance learning are unlikely to gain complete knowledge. There
Electron Beam Linear Accelerators Market Analysis With Industry Share Insights S …
Electron Beam Linear Accelerators Market: Overview According to the report, the global electron beam linear accelerators market was valued at ~US$ 331 Mn in 2019 and is projected to expand at a moderate CAGR from 2020 to 2030. Electron beam linear accelerators are innovative particle accelerators, which use high energy X-rays or electrons to locate and conform tumor shape, consequently destroying cancer cells. The global electron beam linear accelerators market is
More Releases for Atrial
Atrial Fibrillation Device Market Latest Trends and Forecast Analysis - 2026
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Fibrillation - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atrial Fibrillation - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body.
Atrial Fibrillation Market – Global Industry Insights 2024
Atrial fibrillation or A-fib or AF is an irregular heart beat exemplified by rapid and abnormal beating of the heart. The process usually starts as short periods of uncharacteristic beating that become elongated and constant over a period of time. Most episodes have little or no symptoms. Intermittently there can be palpitations in the heart, lightheadedness, fainting, chest pain, or shortness of breath, among others. Atrial fibrillation is linked with